We report the case of attempted suicide by a 30-year-old man who had significant cognitive deficits that developed after at least three years of polysubstance use with cannabis, methylenedioxymethamphetamine (MDMA, "ecstasy") and cocaine. The patient reported increasing difficulties in his professional and interpersonal life which may have been associated with his cognitive dysfunction caused by his poly-drug use. In this setting, the patient complained of increasing symptoms of depression, including feelings of hopelessness and helplessness, and multi somatic complaints (based on DSM-IV criteria). These depressive symptoms led to the development of active suicidal ideation and ultimately to a suicide attempt. We propose that the patient's ...
There are connection between use of cannabis and many psychiatric disturbances in adolescents, espec...
Objective: The present study was conducted to identify risk and prediction factors of suicide attemp...
Pegylated interferon-alpha combined with ribavirin is the current gold standard treatment for chroni...
The report describes a patient who presented suicidal ideation only in two different occasions, imme...
The report describes a patient who presented suicidal ideation only in two different occasions, imme...
Cannabis is one of the most common illegal psychoactive substance used in European countries, in par...
Background In the present study, we examined the relationship between cannabis involvement and suici...
OBJECTIVES Cannabis use is associated with suicide risk in the general population; however, it is un...
Globally, suicide has emerged as the second leading cause of death among youth aged 10–24 years old....
Background: In the present study, we examined the relationship between cannabis involvement and suic...
Objective: Methamphetamine as a recreational drug has undergone cycles of popularity, with a recent ...
Background: Patients suffering from suicidal behaviors among substance abusers are common. Although ...
Background: In the present study, we examined the relationship between cannabis involvement and suic...
Evidence linking cannabis use and depression remains inconsistent. Variations of clinical features w...
Objective To identify whether drug abuse is a risk factor for potentially more harmful methods of su...
There are connection between use of cannabis and many psychiatric disturbances in adolescents, espec...
Objective: The present study was conducted to identify risk and prediction factors of suicide attemp...
Pegylated interferon-alpha combined with ribavirin is the current gold standard treatment for chroni...
The report describes a patient who presented suicidal ideation only in two different occasions, imme...
The report describes a patient who presented suicidal ideation only in two different occasions, imme...
Cannabis is one of the most common illegal psychoactive substance used in European countries, in par...
Background In the present study, we examined the relationship between cannabis involvement and suici...
OBJECTIVES Cannabis use is associated with suicide risk in the general population; however, it is un...
Globally, suicide has emerged as the second leading cause of death among youth aged 10–24 years old....
Background: In the present study, we examined the relationship between cannabis involvement and suic...
Objective: Methamphetamine as a recreational drug has undergone cycles of popularity, with a recent ...
Background: Patients suffering from suicidal behaviors among substance abusers are common. Although ...
Background: In the present study, we examined the relationship between cannabis involvement and suic...
Evidence linking cannabis use and depression remains inconsistent. Variations of clinical features w...
Objective To identify whether drug abuse is a risk factor for potentially more harmful methods of su...
There are connection between use of cannabis and many psychiatric disturbances in adolescents, espec...
Objective: The present study was conducted to identify risk and prediction factors of suicide attemp...
Pegylated interferon-alpha combined with ribavirin is the current gold standard treatment for chroni...